Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B3415 Solifenacin hydrochlorideSummary: muscarinic receptor antagonist
- B3433 Flavoxate hydrochlorideSummary: muscarinic AChR antagonist
- B3475 AceclofenacSummary: non-steroidal anti-inflammatory drug
- B3505 DiclofenacSummary: non-selective COX inhibitor
- B3518 AlcaftadineSummary: H1 histamine receptor antagonist
- B3524 BilastineSummary: H1 histamine receptor antagonist
- B3532 AcetaminophenSummary: COX inhibitor
- B3541 CabergolineSummary: potent dopamine receptor agonist
- B3584 ATB-346Summary: Non-steroidal anti-inflammatory drug
- B3676 RotundineSummary: Dopamine D1 receptor antagonist,potent and selective